257 related articles for article (PubMed ID: 11076391)
1. [Genetic counseling in cystic fibrosis].
Julia S; Bieth E
Rev Mal Respir; 2000 Aug; 17(3 Pt 2):807-11. PubMed ID: 11076391
[TBL] [Abstract][Full Text] [Related]
2. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
[TBL] [Abstract][Full Text] [Related]
3. [Cystic fibrosis: the CFTR gene, its mutations, the genetic counseling].
Goossens M; Ghanem N; Girodon E; Costes B; Fanen P
Rev Pneumol Clin; 1995; 51(3):130-6. PubMed ID: 7569574
[TBL] [Abstract][Full Text] [Related]
4. Carrier screening for cystic fibrosis.
Dungan JS
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
[TBL] [Abstract][Full Text] [Related]
5. Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls.
Weiss FU; Simon P; Bogdanova N; Mayerle J; Dworniczak B; Horst J; Lerch MM
Gut; 2005 Oct; 54(10):1456-60. PubMed ID: 15987793
[TBL] [Abstract][Full Text] [Related]
6. Screening practices for mutations in the CFTR gene ABCC7.
Girodon-Boulandet E; Cazeneuve C; Goossens M
Hum Mutat; 2000; 15(2):135-49. PubMed ID: 10649490
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterisation of circulating fetal cells allows non-invasive prenatal diagnosis of cystic fibrosis.
Saker A; Benachi A; Bonnefont JP; Munnich A; Dumez Y; Lacour B; Paterlini-Brechot P
Prenat Diagn; 2006 Oct; 26(10):906-16. PubMed ID: 16832834
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis mutations with widely variable phenotype: the D1152H example.
Mussaffi H; Prais D; Mei-Zahav M; Blau H
Pediatr Pulmonol; 2006 Mar; 41(3):250-4. PubMed ID: 16429425
[TBL] [Abstract][Full Text] [Related]
9. Screening for mutations in the cystic fibrosis transmembrane regulator gene in an infertility clinic.
Slostad J; Stein QP; Flanagan JD; Hansen KA
Fertil Steril; 2007 Dec; 88(6):1687-8. PubMed ID: 17482604
[TBL] [Abstract][Full Text] [Related]
10. Description of a symptomless cystic fibrosis L346P/M348K compound heterozygous Cypriot individual.
Deltas CC; Boteva K; Georgiou A; Papageorgiou E; Georgiou C
Mol Cell Probes; 1996 Aug; 10(4):315-8. PubMed ID: 8865181
[TBL] [Abstract][Full Text] [Related]
11. Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism.
D'Apice MR; Gambardella S; Russo S; Lucidi V; Nardone AM; Pietropolli A; Novelli G
Prenat Diagn; 2004 Dec; 24(12):981-3. PubMed ID: 15614862
[TBL] [Abstract][Full Text] [Related]
12. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
Schwartz M
Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
[TBL] [Abstract][Full Text] [Related]
13. [The type and frequency of mutations in CFTR gene occurrence in patients with cystic fibrosis in Poland--implication of results obtained from genetic counseling and diagnostic screening].
Bal J; Maciejko D; Mazurczak T
Pediatr Pol; 1995 Aug; 70(8):627-32. PubMed ID: 8668362
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis screening.
Shulman LP
J Midwifery Womens Health; 2005; 50(3):205-10. PubMed ID: 15894998
[TBL] [Abstract][Full Text] [Related]
15. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
16. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.
Bobadilla JL; Farrell MH; Farrell PM
Adv Pediatr; 2002; 49():131-90. PubMed ID: 12214770
[No Abstract] [Full Text] [Related]
17. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
Romey MC
Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
[TBL] [Abstract][Full Text] [Related]
18. Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia.
Banjar H
East Mediterr Health J; 1999 Nov; 5(6):1230-5. PubMed ID: 11924117
[TBL] [Abstract][Full Text] [Related]
19. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.
Preumont V; Hermans MP; Lebecque P; Buysschaert M
Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503
[TBL] [Abstract][Full Text] [Related]
20. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
Narzi L; Ferraguti G; Stamato A; Narzi F; Valentini SB; Lelli A; Delaroche I; Lucarelli M; Strom R; Quattrucci S
Clin Genet; 2007 Jul; 72(1):39-46. PubMed ID: 17594398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
